Lyell Immunopharma Inc (LYEL)

Finanzdaten der Lyell Immunopharma Inc-Aktie (LYEL)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	100.00%0.00	0.00	0.01	0.02	0.01
	6.95%47.34	44.26	127.65	37.27	47.15
Research and Development	7.98%39.52	36.60	-	28.17	34.86
Operating Income/Loss	6.95%-47.34	-44.26	-127.64	-37.25	-47.14
Nonoperating Income/Loss	87.16%2.58	20.11	-13.08	-1.59	4.46
	85.30%-44.76	-24.15	-140.72	-38.85	-42.68
Attributable To Parent	85.30%-44.76	-24.15	-140.72	-38.85	-42.68
Basic Average Shares	6.80%23.36	21.88	-	18.27	14.79
Diluted Average Shares	6.80%23.36	21.88	-	18.27	14.79
Basic Earnings Per Share	74.55%-1.92	-1.10	-	-2.13	-2.89
Diluted Earnings Per Share	74.55%-1.92	-1.10	-	-2.13	-2.89